Stereotactic radiotherapy in oligometastatic cancer.
暂无分享,去创建一个
[1] N. Lawrentschuk,et al. Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial , 2017, BJU international.
[2] C. Abboud. "The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894" (1894), by William Stewart Halsted , 2017 .
[3] Joe Y. Chang,et al. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. , 2017, Practical radiation oncology.
[4] T. de Baère,et al. The role of image-guided therapy in the management of colorectal cancer metastatic disease. , 2017, European journal of cancer.
[5] M. Scorsetti,et al. Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours , 2017, Journal of Cancer Research and Clinical Oncology.
[6] V. De Sanctis,et al. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long‐Term Follow‐Up , 2017, Clinical colorectal cancer.
[7] E. Ruffini,et al. Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).
[8] P. Pagès,et al. Risk factors for survival and recurrence after lung metastasectomy. , 2016, The Journal of surgical research.
[9] A. Louie,et al. Ccr New Strategies New Strategies in Stereotactic Radiotherapy for Oligometastases Disclosure of Potential Conflicts of Interest Editor's Disclosures Cme Staff Planners' Disclosures Learning Objectives Acknowledgment of Financial or Other Support , 2022 .
[10] K. Pienta,et al. The biology and treatment of oligometastatic cancer , 2015, Oncotarget.
[11] T. de Baère,et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] David A. Palma,et al. The oligometastatic state—separating truth from wishful thinking , 2014, Nature Reviews Clinical Oncology.
[13] Umberto Ricardi,et al. An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. , 2014, Clinical lung cancer.
[14] Wendong Gu,et al. Frameless stereotactic body radiation therapy for multiple lung metastases , 2014, Journal of applied clinical medical physics.
[15] Deepinder P. Singh,et al. Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung. , 2014, Journal of thoracic disease.
[16] M De Ridder,et al. Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] R. Weichselbaum,et al. Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma , 2013, American journal of clinical oncology.
[18] Bruce A. Robertson,et al. The Cancer Diaspora: Metastasis beyond the Seed and Soil Hypothesis , 2013, Clinical Cancer Research.
[19] H. Groen,et al. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] A. Bezjak,et al. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).
[21] T. Gruenberger,et al. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab , 2012, The British journal of surgery.
[22] A. Viale,et al. Comparative genomic analysis of primary versus metastatic colorectal carcinomas. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] B. Yaremko,et al. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial , 2012, BMC Cancer.
[24] P. Okunieff,et al. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. , 2012, International journal of radiation oncology, biology, physics.
[25] P. Brown,et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. , 2012, The Lancet. Oncology.
[26] Stephen Breen,et al. A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada , 2012, Radiation oncology.
[27] R. Weichselbaum,et al. Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[28] Joshua D. Lawson,et al. A survey of stereotactic body radiotherapy use in the United States , 2011, Cancer.
[29] P Kirkbride,et al. Stereotactic body radiotherapy. Guidelines for commissioners, providers and clinicians: a national report. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).
[30] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[31] L. Constine,et al. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. , 2010, International journal of radiation oncology, biology, physics.
[32] B. Kavanagh,et al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control , 2010, Radiation oncology.
[33] Y. Niibe,et al. Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy , 2010, Japanese journal of clinical oncology.
[34] M. Wirth,et al. Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease‐free interval and the number of metastases per patient , 2009, International journal of cancer.
[35] A. Muhs,et al. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy , 2009, Breast Cancer Research and Treatment.
[36] L. Gaspar,et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] G. Lockwood,et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Masahiro Hiraoka,et al. Stereotactic body radiotherapy for oligometastatic lung tumors. , 2008, International journal of radiation oncology, biology, physics.
[39] I. B. Borel Rinkes,et al. RADIOFREQUENCY ABLATION (RFA) COMBINED WITH CHEMOTHERAPY FOR UNRESECTABLE COLORECTAL LIVER METASTASES (CRC LM): INTERIM RESULTS OF A RANDOMISED PHASE II STUDY OF THE EORTC-NCRI CCSG-ALM INTERGROUP 40004 (CLOCC) , 2008 .
[40] Matthias Guckenberger,et al. Positioning accuracy of cone-beam computed tomography in combination with a HexaPOD robot treatment table. , 2007, International journal of radiation oncology, biology, physics.
[41] R. Brasacchio,et al. Solitary metastases: illusion versus reality. , 2006, Seminars in radiation oncology.
[42] S. Gallinger,et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. , 2006, Journal of the American College of Surgeons.
[43] J. Petersen,et al. Phase II study on stereotactic body radiotherapy of colorectal metastases , 2006, Acta oncologica.
[44] J. Cheville,et al. Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness , 2005, Clinical Cancer Research.
[45] Samuel Ryu,et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. , 2004, International journal of radiation oncology, biology, physics.
[46] Maria Werner-Wasik,et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.
[47] M. Pocard,et al. Local Recurrences After Intraoperative Radiofrequency Ablation of Liver Metastases: A Comparative Study with Anatomic and Wedge Resections , 2004, Annals of Surgical Oncology.
[48] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[49] J. Grange,et al. Campbell De Morgan's 'Observations on cancer', and their relevance today. , 2002, Journal of the Royal Society of Medicine.
[50] W. Meyers,et al. Liver metastases from breast cancer: long-term survival after curative resection. , 2000, Surgery.
[51] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[52] B. Nordlinger,et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.
[53] S. Hellman,et al. Karnofsky Memorial Lecture. Natural history of small breast cancers. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] Y Maruyama,et al. A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.
[55] I. Fidler,et al. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. , 1986, Cancer research.
[56] B. Fisher. Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. , 1980, Cancer research.
[57] I. Fidler,et al. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. , 1980, Cancer research.
[58] D. Robb. Pulmonary resection for metastatic malignancy. Three cases secondary to hypernephroma , 1948, The British journal of surgery.
[59] R. A. Willis. The Spread of Tumours in the Human Body , 1934, Nature.
[60] W. Halsted. I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. , 1907, Annals of surgery.
[61] W. Halsted,et al. I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. , 1894, Annals of surgery.
[62] R. Hales,et al. NRG Oncology/RTOG 0937: Randomized Phase 2 Study Comparing Prophylactic Cranial Irradiation (PCI) Alone to PCI and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC) , 2016 .
[63] Katsumasa Nakamura,et al. Survey of advanced radiation technologies used at designated cancer care hospitals in Japan. , 2014, Japanese journal of clinical oncology.
[64] M Buyse,et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. , 1997, The Journal of thoracic and cardiovascular surgery.
[65] I. Lax,et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. , 1994, Acta oncologica.
[66] M. Mehta,et al. Defining the role of radiosurgery in the management of brain metastases. , 1992, International journal of radiation oncology, biology, physics.
[67] R A Bakay,et al. Stereotactic radiosurgery. , 1990, Journal of the Medical Association of Georgia.